COMP <GO>
CAVA vs PG // RSI-14 & 200D SMA MOMENTUM
CAVA Group Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CAVA 4
— PG 11
▲ RSI-14 & 200D SMA MOMENTUM LEADER: PG
LAST: $58.74 (-0.79%) • MKT CAP: $6.92B
rsi-technicals
58.9
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
rsi-technicals
62.7
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CAVA VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CAVA | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.90% | 25.40% | -19.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 36.2x | 16.2x | +20.00 | PG | /valuation <GO> |
| Free Cash Flow Yield | 0.38% | 3.77% | -3.39 | PG | /fcf-yield <GO> |
| Operating Margin | 4.70% | 24.30% | -19.60 | PG | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 19.00% | -13.60 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 22.40% | 0.30% | +22.10 | CAVA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.13 | 5.59 | +2.54 | CAVA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | CAVA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.50% | +0.90 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 58.9 | 62.7 | -3.81 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 0.87 | +0.28 | CAVA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 91.1x | 21.7x | +69.40 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.92B | $372.21B | -$365.30B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CAVA REV | PG REV | CAVA GROSS % | PG GROSS % | CAVA FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.18B | $84.28B | 44.0% | 51.2% | $26.1M | $14.04B |
| FY 2024 | $963.7M | $84.04B | 44.0% | 51.4% | $52.9M | $16.52B |
| FY 2023 | $728.7M | $82.01B | 44.0% | 44.0% | $64.3M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CAVA // BETA 1.15
PG // BETA 0.87